Micellar drug delivery systems for hydrophobic drugs

Details Micellar drug delivery systems for hydrophobic drugs Micellar drug delivery systems for hydrophobic drugs

2011-01-25

2011-01-25

Truong, Duc (Department: 1796)

Synthetic resins or natural rubbers -- part of the class 520 ser

Synthetic resins

Mixing of two or more solid polymers; mixing of solid...

C525S088000, C525S419000, C525S420000, C528S354000, C424S078170

Reexamination Certificate

active

07875677

ABSTRACT:
This invention provides compositions comprising a hydrophobic drug, a biocompatible micelle forming polymer, and a biocompatible low molecular weight, water-soluble polymer. Also provided are devices for injection of such compositions and for the use of such compositions to form hydrophobic drug containing micelles within the body of a patient.

REFERENCES:
patent: 4419340 (1983-12-01), Yolles
patent: 4526938 (1985-07-01), Churchill et al.
patent: 4650913 (1987-03-01), Feiring
patent: 4745160 (1988-05-01), Churchill et al.
patent: 4814470 (1989-03-01), Colin et al.
patent: 4857653 (1989-08-01), Colin et al.
patent: 4942184 (1990-07-01), Haugwitz et al.
patent: 5059699 (1991-10-01), Kingston et al.
patent: 5200534 (1993-04-01), Rao
patent: 5202448 (1993-04-01), Carver et al.
patent: 5229529 (1993-07-01), Ueno et al.
patent: 5248796 (1993-09-01), Chen et al.
patent: 5254580 (1993-10-01), Chen et al.
patent: 5272171 (1993-12-01), Ueda et al.
patent: 5274137 (1993-12-01), Nicolaou et al.
patent: 5278324 (1994-01-01), Kingston et al.
patent: 5279949 (1994-01-01), Nair
patent: 5283253 (1994-02-01), Holton et al.
patent: 5294637 (1994-03-01), Chen et al.
patent: 5300638 (1994-04-01), Farina et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5352805 (1994-10-01), Kingston et al.
patent: 5362831 (1994-11-01), Mongelli et al.
patent: 5380751 (1995-01-01), Chen et al.
patent: 5393895 (1995-02-01), Gaullier et al.
patent: 5393896 (1995-02-01), Margraff
patent: 5395850 (1995-03-01), Roth
patent: 5411984 (1995-05-01), Kingston et al.
patent: 5412092 (1995-05-01), Rey et al.
patent: 5422364 (1995-06-01), Nicolaou et al.
patent: 5430021 (1995-07-01), Rudnic et al.
patent: 5440056 (1995-08-01), Klein et al.
patent: 5453521 (1995-09-01), Gaullier et al.
patent: 5478860 (1995-12-01), Wheeler et al.
patent: 5484809 (1996-01-01), Hostetler et al.
patent: 5510103 (1996-04-01), Yokoyama et al.
patent: 5543158 (1996-08-01), Gref et al.
patent: 5645856 (1997-07-01), Lacy et al.
patent: 5716981 (1998-02-01), Hunter et al.
patent: 5717103 (1998-02-01), Denis et al.
patent: 5736366 (1998-04-01), Margraff
patent: 5776486 (1998-07-01), Castor et al.
patent: 5811447 (1998-09-01), Kunz et al.
patent: 5827533 (1998-10-01), Needham
patent: 5827541 (1998-10-01), Yarwood et al.
patent: 5834019 (1998-11-01), Gergely et al.
patent: 5843891 (1998-12-01), Sherman
patent: 5886026 (1999-03-01), Hunter et al.
patent: 5916596 (1999-06-01), Desai et al.
patent: 5939454 (1999-08-01), Schwalge et al.
patent: 5955509 (1999-09-01), Webber et al.
patent: 5968972 (1999-10-01), Broder et al.
patent: 5977375 (1999-11-01), Denis et al.
patent: 5981568 (1999-11-01), Kunz et al.
patent: 5994341 (1999-11-01), Hunter et al.
patent: 6004573 (1999-12-01), Rathi et al.
patent: 6017948 (2000-01-01), Rubinfeld et al.
patent: 6040330 (2000-03-01), Hausheer et al.
patent: 6107332 (2000-08-01), Ali et al.
patent: 6117949 (2000-09-01), Rathi et al.
patent: 6136846 (2000-10-01), Rubinfeld et al.
patent: 6153193 (2000-11-01), Kabanov et al.
patent: 6210717 (2001-04-01), Choi et al.
patent: 6231600 (2001-05-01), Zhong
patent: 6306421 (2001-10-01), Kunz et al.
patent: 6322805 (2001-11-01), Kim et al.
patent: 6358989 (2002-03-01), Kunz et al.
patent: 6365173 (2002-04-01), Domb et al.
patent: 6369037 (2002-04-01), Kim et al.
patent: 6495579 (2002-12-01), Hunter
patent: 6506411 (2003-01-01), Hunter et al.
patent: 6515016 (2003-02-01), Hunter
patent: 6544544 (2003-04-01), Hunter et al.
patent: 6592899 (2003-07-01), Fowers et al.
patent: 6616941 (2003-09-01), Seo et al.
patent: 6689803 (2004-02-01), Hunter
patent: 2 488 385 (2003-12-01), None
patent: 2 490 007 (2004-01-01), None
patent: 1 070 502 (2001-01-01), None
patent: 0 720 471 (2001-04-01), None
patent: 1 092 433 (2001-04-01), None
patent: 0 941 089 (2001-05-01), None
patent: 1 127 570 (2001-08-01), None
patent: 0 590 267 (2002-05-01), None
patent: 0 706 376 (2007-08-01), None
patent: 93/10076 (1993-05-01), None
patent: WO 93/23555 (1993-11-01), None
patent: 93/24476 (1993-12-01), None
patent: 94/00156 (1994-01-01), None
patent: 94/07880 (1994-04-01), None
patent: 94/20089 (1994-09-01), None
patent: 95/03036 (1995-02-01), None
patent: 97/10849 (1997-03-01), None
patent: 97/27855 (1997-08-01), None
patent: 97/40823 (1997-11-01), None
patent: 98/07434 (1998-02-01), None
patent: 98/24427 (1998-06-01), None
patent: 99/21908 (1999-05-01), None
patent: 99/32151 (1999-07-01), None
patent: 99/43343 (1999-09-01), None
patent: 99/62510 (1999-12-01), None
patent: 01/05379 (2001-01-01), None
patent: 01/12718 (2001-02-01), None
patent: 01/30319 (2001-05-01), None
patent: 01/45742 (2001-06-01), None
patent: 01/85216 (2001-11-01), None
patent: 01/87345 (2001-11-01), None
patent: 02/072150 (2002-09-01), None
patent: WO 02/087563 (2002-11-01), None
patent: 03/041689 (2003-05-01), None
patent: 2004/011275 (2004-02-01), None
Bishop et al., “Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer,”Journal of Clinical Oncology17(8):2355-2364, Aug. 1999.
Burt et al., “Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel,”Colloids and Surfaces B: Biointerfaces16(1):161-171, Nov. 1999.
Dordunoo et al., “Taxol encapsulation in poly(ε-caprolactone) microspheres,”Cancer Chemother. Pharmacol. 36(4):279-282, 1995.
Gao et al., “A Model of Micellization for Block Copolymers in Solutions,”Macromolecules26(26):7353-7360, 1993.
Georg et al., “Synthesis of Biologically Active Taxol Analogues with Modified Phenylisoserine Side Chains,”J. Med. Chem. 35(22):4230-4237, 1992.
Gimon et al., “Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry of Paclitaxel and Related Taxanes,”Journal of Natural Products, 57(10):1404-1410, Oct. 1994.
Gu{hacek over (e)}ritte-Voegelein et al., “Relationships between the Structure of Taxol Analogues and Their Antimitotic Activity,”J. Med. Chem. 34(3):992-998, Mar. 1991.
Ha et al., “Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (Pluronic)/poly(ε-caprolactone) (PCL) amphiphilic block copolymeric nanospheres I. Preparation and characterization,”Journal of Controlled Release62(3):381-392, 1999.
Hamad et al., “Theory of Micelle Formation by Amphiphilic Side-Chain Polymers,”Macromolecules, 23(19):4185-4191, Sep. 17, 1990.
Holton et al., “A Synthesis of Taxusin,”J. Am. Chem. Soc. 110(19):6558-6560, Sep. 14, 1988.
Inoue et al., “An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs,”Journal of Controlled Release51(2):221-229, Feb. 12, 1998.
Jackson et al., “A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice,”British Journal of Cancer75(7):1014-1020, 1997.
Jackson et al., “The Suppression of Human Prostate Tumor Growth in Mice by the Intratumoral Injection of a Slow-Release Polymeric Paste Formulation of Paclitaxel,”Cancer Research60(15):4146-4151, Aug. 1, 2000.
Kataoka et al., “Doxorubicin-loaded poly(ethylene glycol)-poly(β-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance,”Journal of Controlled Release64(1-3):143-153, Feb. 2000.
Kim et al., “Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours,”Journal of Controlled Release51:13-22, 1998.
Kim et al., “Amphiphilic diblock copolymeric nanospheres composed of methoxy poly(ethylene glycol) and glycolide: properties, cytotoxicity and drug release behaviour,”Biomaterials20(11):1033-1042, 1999.
Kim et al., “Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(ε-caprolactone) (PCL) amphiphilic block copolymeric nanospheres II. Thermo-

Affiliated with

Also associated with

Rating

Micellar drug delivery systems for hydrophobic drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Micellar drug delivery systems for hydrophobic drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Micellar drug delivery systems for hydrophobic drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2724585